Rapid point-of-care EEG gives clinicians real-time diagnosis options, Ceribell, Inc. argues

Rapid point-of-care EEG gives clinicians real-time diagnosis options, Ceribell, Inc. argues
Ceribell, Inc. urges rapid EEG use

Ceribell, Inc. is calling attention to the critical role of rapid point-of-care EEG in identifying non-convulsive seizures, especially in comatose patients.

According to Dr. Thomas Bleck, without an EEG, clinicians cannot reliably determine if a patient is experiencing non-convulsive status epilepticus. Non-convulsive seizures are often missed due to subtle or absent outward symptoms, posing risks to patient outcomes if undetected. Ceribell, Inc. asserts that deploying EEG technology at the bedside enables immediate neurodiagnostic insight, allowing faster intervention and improved care.

Ceribell recently hosted a webinar promoting point-of-care EEG use to improve seizure diagnosis in critical care and ICU settings. The company has also recognized staff contributions, presenting its Citizens Award to Associate Director of Training Alex Purcell for leadership in staff development initiatives (article). These efforts highlight Ceribell’s focus on rapid EEG technology and employee training.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.